These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer.
    Author: Shah AJ, Parsons B, Pope I, Callaway M, Finch-Jones MD, Thomas MG.
    Journal: Clin Imaging; 2009; 33(3):209-12. PubMed ID: 19411027.
    Abstract:
    AIMS: To compare the clinical utility of contrast enhanced magnetic resonance imaging (MRI) to ultrasound (USS) and computed tomography (CT) in focal hepatic lesions (FHLs) METHODS: This retrospective study analysed 125 consecutive iron oxide enhanced (SPIO) MRI. RESULTS: MRI made a difference in 74% of patients who had USS and in 42% of patients who had a CT scan. In suspected cancer, MRI changed diagnosis in 58% and 37% (13/35), respectively. CONCLUSIONS: MRI is superior to other noninvasive imaging modalities for lesion identification and characterisation.
    [Abstract] [Full Text] [Related] [New Search]